MaxPro Medical
MaxPro Medical
Italy represents one of the most sophisticated medical device markets in Europe. With the "Piano Nazionale di Ripresa e Resilienza" (PNRR) investing heavily in digital health and decentralized care, there is a massive shift from hospital-centric diagnostics to pharmacy-based and home-based monitoring. Cardiovascular disease remains a primary health concern in Italy, driving the demand for high-accuracy cholesterol and lipid profile meters.
For Italian importers and distributors, compliance with the EU Medical Device Regulation (MDR 2017/745) is non-negotiable. Our manufacturing process at MaxPro Medical adheres to ISO 13485 standards, ensuring that every cholesterol meter exported to Milan, Rome, or Naples meets the rigorous precision requirements expected by European clinicians.
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. We operate a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. For the Italian market, we provide Information Gain by integrating AI-enhanced biosensor technology into our meters, providing faster results than traditional wet chemistry labs.
In Italy, pharmacies are the first point of contact for health screening. Our multi-monitoring systems allow pharmacists to provide "Auto-analisi del sangue" services for cholesterol, uric acid, and glucose in under 2 minutes.
With Italy's high percentage of elderly citizens, home monitoring is vital. Our devices feature large LCD screens and simple operations, perfect for senior patients managing chronic dyslipidemia at home.
Major Italian corporations are adopting employee health screening. Our portable lipid analyzers are used for mobile health check-ups in industrial hubs like Turin and Bologna.
The industry is moving towards non-invasive and minimally invasive technologies. As a forward-thinking factory, MaxPro is researching light-scattering technologies for lipid measurement. Currently, our 7-in-1 biochemical meters represent the pinnacle of POCT technology, combining renal function and lipid profile testing in a handheld device.
We are shifting from "selling devices" to "providing diagnostic ecosystems." This includes the meter, the cloud-based management app, and the sustainable supply of high-sensitivity test strips. For global procurement officers, this means lower Total Cost of Ownership (TCO) and higher patient adherence.
